Need help finding what you are looking for?
Contact Us
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1358235
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1358235
Humira Biosimilar Market, By Product, By Indication, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
PUBLISHED:
PAGES: 303 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
REPORT HIGHLIGHT
Humira Biosimilar Market size was valued at USD 790.1 Million in 2022, expanding at a CAGR of 20.9% from 2023 to 2030
Humira biosimilars are biologic drugs that are highly similar to the reference biologic drug Humira (adalimumab). Adalimumab is a monoclonal antibody that targets tumor necrosis factor alpha (TNF-α) and is used to treat various autoimmune diseases, including rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. Biosimilars are developed to be comparable in terms of safety, efficacy, and quality to the original drug but are manufactured by different companies after the patent of the reference drug has expired.
Humira Biosimilar Market - Market Dynamics:
- Increasing prevalence of autoimmune diseases and the rising demand for biologic treatments
- The Humira biosimilar market is experiencing significant growth due to the expiration of Humira's patents in certain regions, allowing other pharmaceutical companies to enter the market and produce more affordable versions of the drug. Biosimilars offer cost-effective alternatives to the reference drug, making treatment more accessible to patients and reducing healthcare expenditures. Additionally, the increasing prevalence of autoimmune diseases and the rising demand for biologic treatments have fueled the demand for Humira biosimilars.
- Across the globe, research and diagnostic institutes are engaging in initiatives aligned with government organizations due to the increasing occurrence of autoimmune disorders and the subsequent surge in healthcare spending. The National Institutes of Health (NIH) data reveals that autoimmune disorders rank among the top ten causes of heightened mortality rates in women. As a result, concerted efforts are being made to address these health challenges through collaborative endeavors between institutes and government bodies.
Humira Biosimilar Market - Key Insights:
- As per the analysis shared by our research analyst, the global Humira Biosimilar market is estimated to grow annually at a CAGR of around 20.9% over the forecast period (2023-2030)
- The Humira Biosimilar industry is projected to grow at a significant rate due to increasing prevalence of autoimmune diseases and the rising demand for biologic treatments
- Based on Indication type segmentation, Rheumatoid arthritis was predicted to show maximum market share in the year 2022
- Based on Product segmentation, Reference-Based Biosimilars was the leading type in 2022
- On the basis of region, North America was the leading revenue generator in 2022
Humira Biosimilar Market- Segmentation Analysis:
- The Global Humira Biosimilar Market is segmented on the basis of Product, Indication, and Region.
- The market is divided into three categories based on Product: Reference-Based Biosimilars, Biosimilars with Modified Amino Acid Sequences and Interchangeable Biosimilars . In 2022, the Reference-Based Biosimilars segment is projected to dominate the market Reference-Based Biosimilars are developed by directly comparing their characteristics and performance to the reference drug, Humira (adalimumab). They are manufactured using similar cell lines and processes to produce a highly similar product.
- The market is divided into four categories based on Indication: Rheumatoid arthritis, psoriasis, Crohn's disease and others. The Rheumatoid arthritis equipment segment is anticipated to hold the largest share in revenue. Rheumatoid arthritis is autoimmune disease in which the body's immune system mistakenly attacks the synovium, which is the lining of the membranes that surround the joints. This results in chronic inflammation, leading to joint damage, pain, swelling, and stiffness.
- By blocking TNF-α, adalimumab helps to reduce inflammation and slow down the progression of joint damage, thereby providing relief from the symptoms of rheumatoid arthritis and improving the patient's quality of life. Humira biosimilars are used in the treatment of rheumatoid arthritis because they contain a highly similar version of the active ingredient found in the reference drug Humira (adalimumab). Adalimumab is a monoclonal antibody that specifically targets and inhibits tumor necrosis factor alpha (TNF-α), a protein that plays a key role in causing inflammation in the joints in rheumatoid arthritis.
Humira Biosimilar Market - Geographical Insights:
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Humira Biosimilar Market- Competitive Landscape:
Companies in the Humira biosimilar market are adopting various strategies to gain a competitive edge. These include investing in extensive research and development to ensure the quality and efficacy of their biosimilars, forming strategic partnerships or collaborations to leverage complementary expertise, and expanding their geographic presence to access new markets. Moreover, some companies focus on offering attractive pricing models and excellent after-sales support to attract more customers and enhance their market share.
Recent Developments:
In September 2016, Amjevita (adalimumab-atto) achieved the distinction of being the first FDA-approved biosimilar for Humira. Subsequently, on January 31, 2023, it marked another milestone by becoming the first Humira biosimilar to be launched in the United States. Amjevita is among the approved Humira biosimilars that have received regulatory clearance for treating HS (hidradenitis suppurativa) in adults.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL HUMIRA BIOSIMILAR MARKET KEY PLAYERS
- Amgen
- Samsung Bioepis
- Sandoz (a division of Novartis)
- Mylan (now part of Viatris)
- Boehringer Ingelheim
- Pfizer
- Fresenius Kabi
- Coherus BioSciences
- Merck & Co.
GLOBAL HUMIRA BIOSIMILAR MARKET, BY PRODUCT
- Reference-Based Biosimilars
- Biosimilars with Modified Amino Acid Sequences
- Interchangeable Biosimilars
GLOBAL HUMIRA BIOSIMILAR MARKET, BY INDICATION
- Rheumatoid arthritis
- Psoriasis
- Crohn's disease
- Others
GLOBAL HUMIRA BIOSIMILAR MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Product Code: ANV1743
Table of Contents
1. Humira Biosimilar Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Humira Biosimilar Market Snippet by Product
- 2.1.2. Humira Biosimilar Market Snippet by Indication
- 2.1.3. Humira Biosimilar Market Snippet by Country
- 2.1.4. Humira Biosimilar Market Snippet by Region
- 2.2. Competitive Insights
3. Humira Biosimilar Key Market Trends
- 3.1. Humira Biosimilar Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Humira Biosimilar Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Humira Biosimilar Market Opportunities
- 3.4. Humira Biosimilar Market Future Trends
4. Humira Biosimilar Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Humira Biosimilar Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Humira Biosimilar Market Landscape
- 6.1. Humira Biosimilar Market Share Analysis, 2022
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Humira Biosimilar Market - By Product
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Product, 2022 & 2030 (%)
- 7.1.2. Reference-Based Biosimilars
- 7.1.3. Biosimilars with Modified Amino Acid Sequences
- 7.1.4. Interchangeable Biosimilars
8. Humira Biosimilar Market - By Indication
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Indication, 2022 & 2030 (%)
- 8.1.2. Rheumatoid arthritis
- 8.1.3. Psoriasis
- 8.1.4. Crohn's disease
- 8.1.5. Others
9. Humira Biosimilar Market- By Geography
- 9.1. Introduction
- 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
- 9.2. North America
- 9.2.1. Overview
- 9.2.2. Humira Biosimilar Key Manufacturers in North America
- 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.2.4. North America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.2.5. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.2.6. U.S.
- 9.2.6.1. Overview
- 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.2.6.3. U.S. Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.2.6.4. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.2.7. Canada
- 9.2.7.1. Overview
- 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.2.7.3. Canada Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.2.7.4. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3. Europe
- 9.3.1. Overview
- 9.3.2. Humira Biosimilar Key Manufacturers in Europe
- 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.3.4. Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.3.5. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.6. Germany
- 9.3.6.1. Overview
- 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.6.3. Germany Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.3.6.4. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.7. Italy
- 9.3.7.1. Overview
- 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.7.3. Italy Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.3.7.4. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.8. United Kingdom
- 9.3.8.1. Overview
- 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.8.3. United Kingdom Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.3.8.4. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.9. France
- 9.3.9.1. Overview
- 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.9.3. France Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.3.9.4. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.10. Russia
- 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.10.2. Russia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.3.10.3. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.11. Netherlands
- 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.11.2. Netherlands Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.3.11.3. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.12. Sweden
- 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.12.2. Sweden Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.3.12.3. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.13. Poland
- 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.13.2. Poland Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.3.13.3. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.14. Rest of Europe
- 9.3.14.1. Overview
- 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.3.14.4. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4. Asia Pacific (APAC)
- 9.4.1. Overview
- 9.4.2. Humira Biosimilar Key Manufacturers in Asia Pacific
- 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.4.4. Asia Pacific Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.4.5. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.6. India
- 9.4.6.1. Overview
- 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.6.3. India Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.4.6.4. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.7. China
- 9.4.7.1. Overview
- 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.7.3. China Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.4.7.4. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.8. Japan
- 9.4.8.1. Overview
- 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.8.3. Japan Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.4.8.4. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.9. South Korea
- 9.4.9.1. Overview
- 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.9.3. South Korea Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.4.9.4. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.10. Australia
- 9.4.10.1. Overview
- 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.10.3. Australia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.4.10.4. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.11. Thailand
- 9.4.11.1. Overview
- 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.11.3. Thailand Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.4.11.4. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.12. Indonesia
- 9.4.12.1. Overview
- 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.12.3. Indonesia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.4.12.4. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.13. Philippines
- 9.4.13.1. Overview
- 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.13.3. Philippines Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.4.13.4. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.14. Rest of APAC
- 9.4.14.1. Overview
- 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.14.3. Rest of APAC Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.4.14.4. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.5. Latin America
- 9.5.1. Overview
- 9.5.2. Humira Biosimilar Key Manufacturers in Latin America
- 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.5.4. Latin America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.5.5. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.5.6. Brazil
- 9.5.6.1. Overview
- 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.6.3. Brazil Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.5.6.4. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.5.7. Mexico
- 9.5.7.1. Overview
- 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.7.3. Mexico Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.5.7.4. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.5.8. Argentina
- 9.5.8.1. Overview
- 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.8.3. Argentina Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.5.8.4. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.5.9. Colombia
- 9.5.9.1. Overview
- 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.9.3. Colombia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.5.9.4. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.5.10. Rest of LATAM
- 9.5.10.1. Overview
- 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.5.10.4. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.6. Middle East and Africa
- 9.6.1. Overview
- 9.6.2. Humira Biosimilar Key Manufacturers in Middle East and Africa
- 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.6.4. Middle East and Africa Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.6.6. Saudi Arabia
- 9.6.6.1. Overview
- 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.6.6.4. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.6.7. United Arab Emirates
- 9.6.7.1. Overview
- 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.6.7.4. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.6.8. Israel
- 9.6.8.1. Overview
- 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.8.3. Israel Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.6.8.4. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.6.9. Turkey
- 9.6.9.1. Overview
- 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.9.3. Turkey Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.6.9.4. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.6.10. Algeria
- 9.6.10.1. Overview
- 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.10.3. Algeria Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.6.10.4. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.6.11. Egypt
- 9.6.11.1. Overview
- 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.11.3. Egypt Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.6.11.4. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.6.12. Rest of MEA
- 9.6.12.1. Overview
- 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.12.3. Rest of MEA Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.6.12.4. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10. Key Vendor Analysis- Humira Biosimilar Industry
- 10.1. Competitive Dashboard
- 10.2. Company Profiles
- 10.2.1. Amgen
- 10.2.2. Samsung Bioepis
- 10.2.3. Sandoz (a division of Novartis)
- 10.2.4. Mylan (now part of Viatris)
- 10.2.5. Boehringer Ingelheim
- 10.2.6. Pfizer
- 10.2.7. Fresenius Kabi
- 10.2.8. Coherus BioSciences
- 10.2.9. Merck & Co.
11. 360 Degree Analyst View
12. Appendix
- 12.1. Research Methodology
- 12.2. References
- 12.3. Abbreviations
- 12.4. Disclaimer
- 12.5. Contact Us
Product Code: ANV1743
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Humira Biosimilar Market: Product Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Product
- TABLE Global Humira Biosimilar Market, by Product 2018-2030 (USD Million)
- TABLE Humira Biosimilar Market: Indication Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Indication
- TABLE Global Humira Biosimilar Market, by Indication 2018-2030 (USD Million)
- TABLE Humira Biosimilar Market: Regional snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Humira Biosimilar Market, by Region 2018-2030 (USD Million)
- TABLE North America Humira Biosimilar Market, by Country, 2018-2030 (USD Million)
- TABLE North America Humira Biosimilar Market, by Product, 2018-2030 (USD Million)
- TABLE North America Humira Biosimilar Market, by Indication, 2018-2030 (USD Million)
- TABLE Europe Humira Biosimilar Market, by Country, 2018-2030 (USD Million)
- TABLE Europe Humira Biosimilar Market, by Product, 2018-2030 (USD Million)
- TABLE Europe Humira Biosimilar Market, by Indication, 2018-2030 (USD Million)
- TABLE Asia Pacific Humira Biosimilar Market, by Country, 2018-2030 (USD Million)
- TABLE Asia Pacific Humira Biosimilar Market, by Product, 2018-2030 (USD Million)
- TABLE Asia Pacific Humira Biosimilar Market, by Indication, 2018-2030 (USD Million)
- TABLE Latin America Humira Biosimilar Market, by Country, 2018-2030 (USD Million)
- TABLE Latin America Humira Biosimilar Market, by Product, 2018-2030 (USD Million)
- TABLE Latin America Humira Biosimilar Market, by Indication, 2018-2030 (USD Million)
- TABLE Middle East and Africa Humira Biosimilar Market, by Country, 2018-2030 (USD Million)
- TABLE Middle East and Africa Humira Biosimilar Market, by Product, 2018-2030 (USD Million)
- TABLE Middle East and Africa Humira Biosimilar Market, by Indication, 2018-2030 (USD Million)
List of Figures
- FIGURE Humira Biosimilar Market Segmentation
- FIGURE Market research methodology
- FIGURE Value chain analysis
- FIGURE Porter's Five Forces Analysis
- FIGURE Market Attractiveness Analysis
- FIGURE COVID-19 Impact Analysis
- FIGURE Pre & Post COVID-19 Impact Comparision Study
- FIGURE Competitive Landscape; Key company market share analysis, 2022
- FIGURE Product segment market share analysis, 2022 & 2030
- FIGURE Product segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Indication segment market share analysis, 2022 & 2030
- FIGURE Indication segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Regional segment market share analysis, 2022 & 2030
- FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE North America Humira Biosimilar Market share and leading players, 2022
- FIGURE Europe Humira Biosimilar Market share and leading players, 2022
- FIGURE Asia Pacific Humira Biosimilar Market share and leading players, 2022
- FIGURE Latin America Humira Biosimilar Market share and leading players, 2022
- FIGURE Middle East and Africa Humira Biosimilar Market share and leading players, 2022
- FIGURE North America market share analysis by country, 2022
- FIGURE U.S. Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Canada Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Europe Humira Biosimilar Market share analysis by country, 2022
- FIGURE Germany Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Spain Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Italy Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE France Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE UK Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Russia Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Netherlands Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Sweden Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Poland Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of the Europe Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Asia Pacific Humira Biosimilar Market share analysis by country, 2022
- FIGURE India Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE China Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Japan Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE South Korea Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Australia Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Thailand Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Indonesia Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Phillipines Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of APAC Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Latin America Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Latin America Humira Biosimilar Market share analysis by country, 2022
- FIGURE Brazil Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Mexico Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Argentina Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Colombia Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of LATAM Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Middle East and Africa Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Middle East and Africa Humira Biosimilar Market share analysis by country, 2022
- FIGURE Saudi Arabia Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE United Arab Emirates Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Israel Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Turkey Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Algeria Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Egypt Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of MEA Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.